Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV)

Journal of Histochemistry and Cytochemistry

Volumn 58, Issue 5, 2010, Pages 405-411

  Guimarães, Marcia C M ^a   Soares, Christiane P ^b   Donadi, Eduardo A ^a   Derchain, Sophie F M ^c   Andrade, Liliana A L A ^c   Silva, Tarsia G A ^b   Hassumi, Marcela K ^a   Simões, Renata T ^a,e   Miranda, Fabiana A ^a   Lira, Régia C P ^a   Crispim, Janaina ^d   Soares, Edson G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^e Núcleo de Pós Graduação e Pesquisa   (Brazil)

Author keywords

HLA G5 isoform; HPV; Immunohistochemistry; Invasive cervical carcinoma; PCR

Indexed keywords

HLA G ANTIGEN; HLA G5 ANTIGEN; UNCLASSIFIED DRUG; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; ISOPROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; BIOSYNTHESIS; CLASSIFICATION; CROSS-SECTIONAL STUDY; ISOLATION AND PURIFICATION; METABOLISM; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

CROSS-SECTIONAL STUDIES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTEIN ISOFORMS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 77951908342     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2009.954131     Document Type: Article

References (37)

1. Adithi M, Kandalam M, Ramkumar HL, Subramanian A, Venkatesan N, Krishnakumar S (2006) Retinoblastoma: expression of HLA-G. Ocul Immunol Inflamm 14:207-213
2. Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS (2005) E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 113:276-283 (Pubitemid 39628318)
3. Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS (2002) Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21:248-259 (Pubitemid 34102133)
4. Barrier BF, Kendall BS, Sharpe-Timms KL, Kost ER (2006) Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 103:25-30
5. Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N (2003) HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81:199-252 (Pubitemid 38009044)
6. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N (2008) HLA-G: from biology to clinical benefits. Trends Immunol 29:125-132
7. Chen CL, Liao QP (2005) [Role of human leukocyte antigen-G small interference RNA in a choriocarcinoma cell line] Zhonghua Fu Chan Ke Za Zhi 40:549-552
8. Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, et al. (1997) Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89:245-250 (Pubitemid 27073762)
9. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63-73 (Pubitemid 36159887)
10. El-Chennawi FA, Auf FA, El-Diasty AM, El-Daim MA, El-Sherbiny SM, Ali A, El-Baz M, et al. (2005) Expression of HLA-G in cancer bladder. Egypt J Immunol 12:57-64
11. Frank TS, Svoboda-Newman SM, Hsi ED (1996) Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. Diagn Mol Pathol 5:220-224
12. Fule T, Csapo Z, Mathe M, Tatrai P, Laszlo V, Papp Z, Kovalszky I (2006) Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol Oncol 100:570-578 (Pubitemid 43246875)
13. Georgopoulos NT, Proffitt JL, Blair GE (2000) Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papilloma-virus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 19: 4930-4935
14. Goncalves MA, Le Discorde M, Simoes RT, Rabreau M, Soares EG, Donadi EA, Carosella ED (2008) Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 141: 70-74
15. Gros F, Sebti Y, de Guibert S, Branger B, Bernard M, Fauchet R, Amiot L (2006) Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 8:223-230 (Pubitemid 43671238)
16. Ishigami S, Natsugoe S, Miyazono F, Nakajo A, Tokuda K, Matsumoto M, Okumura H, et al. (2006) HLA-G expression in gastric cancer. Anticancer Res 26:2467-2472
17. Kleinberg L, Florenes VA, Skrede M, Dong HP, Nielsen S, McMaster MT, Nesland JM, et al. (2006) Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch 449:31-39 (Pubitemid 43988363)
18. Kondo K (2009) [Development of an HPV vaccine: remaining issues and perspective] Nippon Rinsho 67:62-68
19. Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P (2002) Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196:266-274 (Pubitemid 34189414)
20. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474 (Pubitemid 32368042)
21. Nguyen HH, Broker TR, Chow LT, Alvarez RD, Vu HL, Andrasi J, Brewer LR, et al. (2005) Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol 96:452-461 (Pubitemid 40127148)
22. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, et al. (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510-4515 (Pubitemid 28207943)
23. Rebmann V, Wagner S, Grosse-Wilde H (2007) HLA-G expression in malignant melanoma. Semin Cancer Biol 17:422-429
24. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED (2005) HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 65:10139-10144
25. Rouas-Freiss N, Moreau P, Menier C, LeMaoult J, Carosella ED (2007) Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin Cancer Biol 17:413-421 (Pubitemid 350064561)
26. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, et al. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491 (Pubitemid 18084310)
27. Sanguinetti CJ, Dias Neto E, Simpson AJ (1994) Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17:914-921
28. Seliger B, Schlaf G (2007) Structure, expression and function of HLA-G in renal cell carcinoma. Semin Cancer Biol 17:444-450 (Pubitemid 350052590)
29. Sheu JJ, Shih IeM (2007) Clinical and biological significance of HLA-G expression in ovarian cancer. Semin Cancer Biol 17: 436-443 (Pubitemid 350052589)
30. Smyth MJ, Dunn GP, Schreiber RD (2006) Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90:1-50
31. Urosevic M, Dummer R (2008) Human leukocyte antigen-G and cancer immunoediting. Cancer Res 68:627-630 (Pubitemid 351206734)
32. Vermeulen CF, Jordanova ES, ter Haar NT, Kolkman-Uljee SM, de Miranda NF, Ferrone S, Peters AA, et al. (2007) Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma. Gynecol Oncol 105:593-599
33. Vermeulen CF, Jordanova ES, Zomerdijk-Nooijen YA, ter Haar NT, Peters AA, Fleuren GJ (2005) Frequent HLA class I loss is an early event in cervical carcinogenesis. Hum Immunol 66: 1167-1173
34. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19 (Pubitemid 29406813)
35. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM (2007) Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 20: 375-383 (Pubitemid 46348337)
36. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM (2007) Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 58:267-274 (Pubitemid 47516690)
37. Zhou JH, Ye F, Chen HZ, Zhou CY, Lu WG, Xie X (2006) Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Life Sci 78:2643-2649